.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cipla
Mallinckrodt
Federal Trade Commission
Daiichi Sankyo
Dow
US Department of Justice
Cantor Fitzgerald
Baxter
AstraZeneca

Generated: December 13, 2017

DrugPatentWatch Database Preview

Cytarabine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cytarabine and what is the scope of cytarabine patent protection?

Cytarabine
is the generic ingredient in four branded drugs marketed by Pacira Pharms Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Mylan Pharms Inc, Sagent Pharms, Teva Parenteral, West-ward Pharms Int, Teva Pharms Usa, and Celator Pharms, and is included in seventeen NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for cytarabine. Six suppliers are listed for this compound.

Pharmacology for cytarabine

Medical Subject Heading (MeSH) Categories for cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms IntCYTARABINEcytarabineINJECTABLE;INJECTION071472-001Aug 2, 1989RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Celator PharmsVYXEOScytarabine; daunorubicin POWDER;INTRAVENOUS209401-001Aug 3, 2017RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Mylan Labs LtdCYTARABINEcytarabineINJECTABLE;INJECTION200914-001Dec 13, 2011APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Celator PharmsVYXEOScytarabine; daunorubicin POWDER;INTRAVENOUS209401-001Aug 3, 2017RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
HospiraCYTARABINEcytarabineINJECTABLE;INJECTION072945-001Feb 28, 1994APRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Teva ParenteralCYTARABINEcytarabineINJECTABLE;INJECTION016793-003Dec 21, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva ParenteralCYTARABINEcytarabineINJECTABLE;INJECTION016793-004Dec 21, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva ParenteralCYTARABINEcytarabineINJECTABLE;INJECTION016793-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaCYTOSAR-UcytarabineINJECTABLE;INJECTION075206-003Dec 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Celator PharmsVYXEOScytarabine; daunorubicin POWDER;INTRAVENOUS209401-001Aug 3, 2017RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Teva ParenteralCYTARABINEcytarabineINJECTABLE;INJECTION016793-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Teva ParenteralCYTARABINEcytarabineINJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Colorcon
Deloitte
Cantor Fitzgerald
Express Scripts
US Army
McKesson
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot